Front. Pharmacol.Frontiers in PharmacologyFront. Pharmacol.1663-9812Frontiers Media S.A.163300810.3389/fphar.2025.1633008PharmacologyCorrectionCorrection: Cardioprotective effects of the electrolyte solution sterofundin and the possible underlying mechanismsChen et al.10.3389/fphar.2025.1633008ChenMin12†XiaoYingying3†ZhengJijian2†ZhaoPeibin1†ChengLin1JiangChuan4ZhengSixie4WangZheng4SunSijuan5YeLincai46*ChenGuozhen7*ZhangHao1*HuangYanhui2*1Children’s Heart Center, Institute of Cardiovascular Development and Translational Medicine, The Second Affiliated Hospital and Yuying Children’s Hospital, Wenzhou Medical University, Wenzhou, China2Department of Anesthesiology, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China3Department of Thoracic and Cardiovascular Surgery, Shanghai Children’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China4Department of Thoracic and Cardiovascular Surgery, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China5Department of Pediatric Intensive Care Unit, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China6Shanghai Institute For Pediatric Congenital Heart Disease, Shanghai Children’s Medical Center, School of Medicine Shanghai Jiao Tong University, Shanghai, China7Department of Cardiology, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Approved by:Frontiers Editorial Office, Frontiers Media SA, Switzerland
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
A Correction on Cardioprotective effects of the electrolyte solution sterofundin and the possible underlying mechanisms by Chen M, Xiao Y, Zheng J, Zhao P, Cheng L, Jiang C, Zheng S, Wang Z, Sun S, Ye L, Chen G, Zhang H and Huang Y. Front Pharmacol. 15:1449831. doi: 10.3389/fphar.2024.1449831sterofundinelectrolyte solutionsmyocardium infarctionintensive careautophagysection-at-acceptanceCardiovascular and Smooth Muscle Pharmacology
In the published article, there was an error in the affiliations. The order of affiliations 1 and 2 was inverted.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.